IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

April 10-11, 2019

Cambridge Healthtech Institute’s Inaugural Oncolytic Viral Therapy Conference: Engineering, Translational and Clinical Strategies

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Antibody Targeted Viruses: The Next Generation of Oncolytics”

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com